| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,125 | 1,100 | +2.3% |
| EBITDA | −115 | 17.1 | — |
| EBITDA margin | −10.2% | 1.6% | −11.7 pts |
| Profit before tax | −232 | −86.4 | — |
| Net profit | −176 | −64.3 | — |
| EPS | −₹11.10 | −₹4.02 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 3,184 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 430 | 430 | 555 | 724 | 1,111 | ||
| 1,952 | 1,952 | 1,841 | 1,542 | 1,008 | ||
| 4,706 | — | — | — | — | ||
| 4,249 | 4,224 | 4,346 | 3,923 | 4,941 | ||
| — | −2.8% | +10.8% | −20.6% | — | ||
| 66.3 | 198 | 219 | 25.8 | 468 | ||
| 1.6% | 4.7% | 5.0% | 0.7% | 9.5% | ||
| −155 | −15.2 | 19.8 | −126 | 326 | ||
| −391 | −280 | −110 | −158 | 152 | ||
| −9.2% | −6.6% | −2.5% | −4.0% | 3.1% | ||
| −₹24.74 | −₹17.70 | −₹6.98 | −₹9.98 | ₹9.64 | ||
| — | −153.6% | +30.1% | −203.6% | — | ||
| — | 294 | 172 | −245 | 355 | ||
| — | −316 | −382 | −619 | −420 | ||
| −21.8 | −21.8 | −211 | −864 | −64.2 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 3,184.2 | |
| - Cash, Equiv & ST Investments | 1,111.0 | 724.4 | 554.8 | 430.4 | 430.4 | |
| + Total Debt | 1,008.0 | 1,542.3 | 1,840.6 | 1,951.8 | 1,951.8 | |
| Enterprise Value | — | — | — | — | 4,705.7 | |
| Revenue | 4,941.1 | 3,923.0 | 4,346.1 | 4,223.8 | 4,248.6 | |
| Growth %, YoY | — | -20.6 | +10.8 | -2.8 | — | |
| EBITDA | 468.1 | 25.8 | 218.7 | 197.9 | 66.3 | |
| Margin % | 9.47 | 0.66 | 5.03 | 4.69 | 1.56 | |
| EBIT | 326.1 | -125.5 | 19.8 | -15.2 | -154.6 | |
| Net Income | 152.4 | -158.4 | -110.4 | -279.9 | -391.2 | |
| Margin % | 3.08 | -4.04 | -2.54 | -6.63 | -9.21 | |
| EPS, Adj (current shares) | 9.64 | -9.98 | -6.98 | -17.70 | -24.74 | |
| Growth %, YoY | — | -203.6 | +30.1 | -153.6 | — | |
| Cash from Operations | 355.4 | -244.9 | 171.7 | 294.3 | — | |
| Capital Expenditures | -419.6 | -618.9 | -382.2 | -316.1 | — | |
| Free Cash Flow | -64.2 | -863.9 | -210.6 | -21.8 | -21.8 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Chemplast Sanmar (NSE: CHEMPLASTS) had a market capitalisation of ₹3,000 crore at the 30 October 2026 close (₹189.76 a share) and a price-to-book ratio of 1.71. In FY26 its consolidated net loss was ₹280 crore on revenue of ₹4,224 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹176 crore. Its debt-to-equity ratio was 1.11 on 31 March 2026. Promoters held 54.99% of the shares on 30 September 2026.
Chemplast Sanmar's PE ratio is not meaningful at the 30 October 2026 close: its consolidated net profit over the last four quarters (Q2 FY26 to Q1 FY27) was a loss of ₹391 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹3,000 crore at ₹189.76 a share.
Chemplast Sanmar's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,755 crore on 31 March 2026, down 15.2% from ₹2,068 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹3,000 crore at the 30 October 2026 close.
Chemplast Sanmar's book value per share was ₹110.97 on 31 March 2026: shareholders' equity of ₹1,755 crore divided by the 15.81 crore shares in issue, down 15.2% from ₹130.81 a year earlier. The share price at the 30 October 2026 close was ₹189.76.
Chemplast Sanmar's price-to-book (PB) ratio is 1.71 at the 30 October 2026 close: a market capitalisation of ₹3,000 crore divided by shareholders' equity (book value) of ₹1,755 crore on 31 March 2026. That is a book value of ₹110.97 per share against a share price of ₹189.76.
In FY26, Chemplast Sanmar's return on equity (ROE) was −14.6% and its return on capital employed (ROCE) was −0.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −5.9% and ROCE 0.5%.
On 30 September 2026, Chemplast Sanmar's shares were held by promoters 54.99%, foreign portfolio investors (FII/FPI) 10.66%, domestic institutions (DII) 22.41% (including mutual funds at 21.37%) and retail and other non-institutional investors 11.94%. Over the year, FII holding was down 2.49 percentage points from 13.15% and DII holding was down 3.21 percentage points from 25.62%.
Chemplast Sanmar's market capitalisation was ₹3,000 crore at the 30 October 2026 close: 15.81 crore shares at ₹189.76 each.
No. Chemplast Sanmar had borrowings of ₹1,952 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.11. Its cash and current investments were ₹533 crore, so its net debt was ₹1,419 crore.
Chemplast Sanmar's basic earnings per share (EPS) were −₹17.70 in FY26, against −₹6.92 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to −₹24.63.
Chemplast Sanmar's debt-to-equity ratio was 1.11 on 31 March 2026: borrowings of ₹1,952 crore against total equity of ₹1,755 crore. A year earlier, on 31 March 2025, it was 0.89.
In FY26, Chemplast Sanmar generated ₹294 crore of cash from operations and spent ₹316 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹21.8 crore. In FY25 it was −₹211 crore.
In FY26 (April 2025–March 2026), Chemplast Sanmar's consolidated net loss was ₹280 crore, wider than the loss of ₹110 crore in FY25, on revenue from operations of ₹4,224 crore (down 2.8%).
Promoters held 54.99% of Chemplast Sanmar on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Chemplast Sanmar's latest results are for Q1 FY27 (April–June 2026), filed on 6 August 2026: consolidated net loss ₹176 crore, wider than the loss of ₹64.4 crore in Q1 FY26; revenue from operations ₹1,125 crore, up 2.3% year on year.
Chemplast Sanmar will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
On FY26 consolidated figures, against Ddev Plastiks Industries, Rossari Biotech and NOCIL: Chemplast Sanmar's operating margin of −0.4% is the lowest of the four (Ddev Plastiks Industries 9.1%, Rossari Biotech 8.6%, NOCIL 3.5%; peer average 7.1%); its return on equity of −14.6% is the lowest of the four (Ddev Plastiks Industries 21.8%, Rossari Biotech 11.9%, NOCIL 3.2%; peer average 12.3%).
In FY26, Chemplast Sanmar earned net profit of ₹280 crore on revenue of ₹4,224 crore, against ₹202 crore on ₹2,948 crore for Ddev Plastiks Industries. Chemplast Sanmar's operating margin was −0.4% (Ddev Plastiks Industries 9.1%) and its return on equity −14.6% (Ddev Plastiks Industries 21.8%). At the 30 October 2026 close, Chemplast Sanmar's market capitalisation was ₹3,000 crore against ₹2,507 crore for Ddev Plastiks Industries.
From Chemplast Sanmar's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.